2015
DOI: 10.1016/j.surge.2013.10.005
|View full text |Cite
|
Sign up to set email alerts
|

High-resolution, handheld camera use for occult breast lesion localization plus sentinel node biopsy (SNOLL): A single-institution experience with 186 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…breast cancer), resection of neuroendocrine tumors using 123 I-MIBG (e.g. paraganglioma) and resection for thyroid disorders 99m Tc-MIBI [101,149]. To our knowledge, intraoperative usage with PET radiopharmaceuticals has not been shown in literature yet.…”
Section: Portable Gamma (γ) Camerasmentioning
confidence: 98%
“…breast cancer), resection of neuroendocrine tumors using 123 I-MIBG (e.g. paraganglioma) and resection for thyroid disorders 99m Tc-MIBI [101,149]. To our knowledge, intraoperative usage with PET radiopharmaceuticals has not been shown in literature yet.…”
Section: Portable Gamma (γ) Camerasmentioning
confidence: 98%
“…In patients with a non-palpable lesion of the breast evaluation of axillar lymphatic node is one of the most important factors, so the biopsy of sentinel node is very necessary. [10][11][12][13][14]. The combination of ROLL with a biopsy of the sentinel node is called SNOLL (sentinel occult lesion localization) and it was introduced by de Cicco in 2002 [15].…”
Section: Diagnostics and Treatmentmentioning
confidence: 99%
“…High-resolution, handheld cameras have been developed for nonpalpable breast localization plus SLNB or the so-called SNOLL technique (sentinel node and occult lesion localization) that is common in Europe and beginning to be adopted more widely in the USA [38]. These handheld gamma cameras enable intraoperative scintigraphy in real time.…”
Section: Future Developmentsmentioning
confidence: 99%